ANI PHARMACEUTICALS INC — Director's Dealing 2019

Aug 23, 2019

SEC Form 4/A — Form 4/A

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2019-08-19

Reporting Person: MERIDIAN VENTURE PARTNERS II LP (10% Owner)
Reporting Person: Meridian Venture Partners II GP, L.P. (10% Owner)
Reporting Person: Meridian Venture Partners II, Co. (10% Owner)
Reporting Person: Brown Robert E. JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-19	Common Stock	S	2067	$68.30	Disposed	2286795	Direct
2019-08-20	Common Stock	S	5512	$68.18	Disposed	2281283	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $69.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.

F2: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.

F3: Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II.

F4: This Form 4 Amendment is being filed for the sole purpose of reporting that sales under the Reporting Person's 10b5-1 diversification plan has completed, and no further sales will take place under the plan.